This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
A Roadmap for Access
We must secure sustainable markets to ensure patient access to generic and biosimilar medicines
